Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Total Non-Current Liabilities (2016 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Total Non-Current Liabilities for 6 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities fell 24.3% year-over-year to $1.4 million, compared with a TTM value of $1.4 million through Dec 2025, down 24.3%, and an annual FY2025 reading of $2.4 million, up 1.6% over the prior year.
  • Total Non-Current Liabilities was $1.4 million for Q4 2025 at Neuroone Medical Technologies, down from $2.4 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $2.4 million in Q3 2025 and bottomed at $973725.0 in Q1 2021.
  • Average Total Non-Current Liabilities over 3 years is $1.8 million, with a median of $1.8 million recorded in 2024.
  • Peak annual rise in Total Non-Current Liabilities hit 1.6% in 2025, while the deepest fall reached 24.3% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $973725.0 in 2021, then soared by 85.71% to $1.8 million in 2024, then fell by 24.3% to $1.4 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for NMTC at $1.4 million in Q4 2025, $2.4 million in Q3 2025, and $1.6 million in Q2 2025.